Claritin — Class II drug recall D-0266-2026
Ongoing recall by GOLD STAR DISTRIBUTION INC, reported 2026-01-21, distributed nationwide. CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
| Recall number | D-0266-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | GOLD STAR DISTRIBUTION INC, Minneapolis, MN, United States |
| Recall initiated | 2025-12-26 |
| Classified | 2026-01-14 |
| Reported by FDA | 2026-01-21 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00655708016305 |
Product
Claritin, 20 Count, UPC: 655708016305
Reason for recall
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0266-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.